Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 11:13 AM UTC
| NCT Number | NCT06500884 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | PHASE2 |
| Target Enrollment | 210 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Janssen Research & Development, LLC |
| Last Updated on CT.gov | July 6, 2026 (1 week ago) |
As of July 18, 2026: Clinical trial NCT06500884 is currently recruiting participants. This phase2 study for multiple myeloma is actively seeking new participants at 9 locations across the United States. The study is sponsored by Janssen Research & Development, LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06500884 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06500884 was last updated 1 week ago (July 6, 2026). HelloStudys verifies this status automatically.